Pharmaceuticals news continually updated from thousands of sources around the net.
58 min ago | Seeking Alpha
At this time, all participants are in a listen only mode. There will be a presentation followed by a question-and-answer session.
Options to acquire 850,000 common shares were granted to the directors and 80,000 to consultants.
The firm currently has a "buy" rating on the stock. Mizuho's target price indicates a potential upside of 11.54% from the company's current price.
The firm currently has an "outperform" rating on the stock. FBR Capital Markets' target price indicates a potential upside of 9.45% from the stock's previous close.
McKesson Corp.'s earnings fell 5% in its fiscal first quarter, despite double-digit growth in its distribution segment, as charges related to its international technology business and certain one-time items dragged down the company's bottom line.The San Francisco-based pharmaceutical distributor... For the best experience of ModernHealthcare.com on ... (more)
Growing pharma demand in China has led SGS Life Sciences to expand its validation testing and lab service offerings at its Shanghai site.
The UK All-Party Pharmacy Group has warned Britain is suffering from a shortage of branded and generic drugs.
British-Swedish drugmaker AstraZeneca, which fought off a takeover from Pfizer earlier this year, raised its 2014 earnings outlook on Thursday and posted rising second-quarter sales.
Rafarma Pharmaceuticals Inc. announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director of the Company, effective July 15, 2014.
An activist investor calling for change at Teva Pharmaceutical Industries Ltd. said the result of a shareholder vote to reappoint all board members is a victory, and that the level of dissent shows the company will have to listen to stockholders.
Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.
McKesson Corporation, a healthcare services and information technology company, today announced a three-year extension to its pharmaceutical distribution agreement with CVS Caremark.
All Board members were reelected and all Board vote recommendations were upheld.
The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .
Leading up to Teva Pharmaceutical Industries' announcement of its second-quarter earnings on Thursday, July 31, 2014, analysts have become more bullish as expectations have improved over the past month from $1.17 per share to the current projection of earnings of $1.22 per share.
"We have a long t... )--Jamba Inc., a leading healthy active lifestyle brand and the leading retailer of freshly squeezed juice today announced that consumers who visit J... )--Tigermed and Frontage complete strategic investment agreement.
Updated: Fri Aug 01, 2014 04:28 am
Copyright © 2014 Topix LLC